PFPT
ARRY

Pinnacle Financial Partners (Tennessee)’s Array Biopharma Inc ARRY Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-410
Closed -$3K – 216
2013
Q3 		$3K Buy
+410
New +$2.44K ﹤0.01% 211

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s ARRY Position: Q4 2013 in Review

Pinnacle Financial Partners (Tennessee) sold out of Array Biopharma Inc (ARRY) in Q4 2013, closing a stake of 410 shares — an estimated $3K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in ARRY in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 143 funds tracked by Wall St. Rank hold ARRY as of Q4 2013.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Array Biopharma Inc position as of Q4 2013 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 410 Array Biopharma Inc shares in Q4 2013, an estimated $3K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Array Biopharma Inc in Q3 2013 and held it in 1 quarter.
  • Pinnacle Financial Partners (Tennessee)'s Array Biopharma Inc position peaked at $3K in Q3 2013.
  • 143 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2013.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2013, filed 10 Feb 2014.